Basics TransCode Therapeutics, Inc. IPO Date: July 9, 2021 Sector: Healthcare Industry: Biotech Market Cap: $5.91M Activated in VL: True Average Daily Range Avg Daily Range: $0.12 | 6.21% Avg Daily Range (30 D): $0.23 | 6.32% Avg Daily Range (90 D): $0.32 | 7.91% Institutional Daily Volume Avg Daily Volume: 1.8M Avg Daily Volume (30 D): 4.65M Avg Daily Volume (90 D): 5.71M Trade Size Avg Trade Size (Sh.): 341 Avg Trade Size (Sh.) (30 D): 603 Avg Trade Size (Sh.) (90 D): 303 Institutional Trades Total Inst.Trades: 16 Avg Inst. Trade: $.76M Avg Inst. Trade (30 D): $.57M Avg Inst. Trade (90 D): $.57M Avg Inst. Trade Volume: .02M Avg Inst. Trades (Per Day): 2 Market Closing Trades Avg Closing Trade: $.65M Avg Closing Trade (30 D): $M Avg Closing Trade (90 D): $M Avg Closing Volume: .01K     News May 5, 2025 @ 10:27 AM US Stocks Likely To Open Lower After S&P 500's 9-D... Source: Rishabh Mishra Jul 23, 2024 @ 5:26 PM Why Transcode Therapeutics (RNAZ) Stock Is Down 60... Source: Henry Khederian Jun 10, 2024 @ 12:07 PM Beat the Market Like Zacks: Goldman Sachs, Micron,... Source: Abhinab Dasgupta Jun 10, 2024 @ 11:00 AM Nasdaq Determines That TransCode Therapeutics Has ... Source: TransCode Therapeutics, Inc. May 29, 2024 @ 1:15 PM TransCode Therapeutics Reports Positive Data from ... Source: TransCode Therapeutics, Inc. Financials   TTM Q4 2024 FY 2024 Basic EPS $-2.51 $-47.14 Diluted EPS $-2.51 $-47.14 Revenue $ M $ $ M Gross Profit $ $ $ Net Income / Loss $ -12.09M $ $ -16.75M Operating Income / Loss $ -3.17M $ $ -15.66M Cost of Revenue $ $ $ Net Cash Flow $ M $ $ 3.04M PE Ratio     Splits Dec 04, 2024:   1:33 Jan 16, 2024:   1:40 May 23, 2023:   1:20